Sloan Sheldon
Chief Medical Officer at SYRE
- Sold, on record
- $7.4M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jul 1, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SYRESpyre Therapeutics, Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice SYRENoticeApr 1, 2026 2026
Filed to sell 7,958 shares ($401k)
Sloan Sheldon, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale SYRERoutineApr 1, 2026 same day
Sold 7,958 shares at $50.00 ($398k)
Sloan Sheldon, Chief Medical Officer
10b5-1 planSold 100% of holdings ($398k position)0 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice SYRENoticeMay 1, 2026 +30 days
Filed to sell 78,333 shares ($5.8M)
Sloan Sheldon, Officer
10b5-1 planFiling
- 4 Form 4 sale SYRERoutineMay 1, 2026 same day
Sold 78,333 shares at $71.50 ($5.6M)
Sloan Sheldon, Chief Medical Officer
10b5-1 planSold 100% of holdings ($5.6M position)0 shares leftFollows a Form 144Filing
- 5 Form 144 notice SYRENoticeJun 3, 2026 +33 days
Filed to sell 16,667 shares ($1.2M)
Sloan Sheldon, Officer
10b5-1 planFiling
- 6 Form 4 sale SYRERoutineJun 3, 2026 same day
Sold 8,333 shares at $75.00 ($625k)
Sloan Sheldon, Chief Medical Officer
10b5-1 planSold 100% of holdings ($625k position)0 shares leftFollows a Form 144Filing
- 7 Form 4 sale SYRERoutineJul 1, 2026 +28 days
Sold 8,334 shares at $87.70 ($731k)
Sloan Sheldon, Chief Medical Officer
10b5-1 planSold 100% of holdings ($731k position)0 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 2, 2026 | SYRE | Chief Medical Officer | Form 4 sale | 8,334 | $731k | 100.0% | Routine | SEC |
| Jun 3, 2026 | Jun 3, 2026 | SYRE | Chief Medical Officer | Form 4 sale | 8,333 | $625k | 100.0% | Routine | SEC |
| Jun 3, 2026 | Jun 3, 2026 | SYRE | Officer | Form 144 notice | 16,667 | $1.2M | Notice | SEC | |
| May 1, 2026 | May 1, 2026 | SYRE | Chief Medical Officer | Form 4 sale | 78,333 | $5.6M | 100.0% | Routine | SEC |
| May 1, 2026 | May 1, 2026 | SYRE | Officer | Form 144 notice | 78,333 | $5.8M | Notice | SEC | |
| Apr 1, 2026 | Apr 3, 2026 | SYRE | Chief Medical Officer | Form 4 sale | 7,958 | $398k | 100.0% | Routine | SEC |
| Apr 1, 2026 | Apr 1, 2026 | SYRE | Officer | Form 144 notice | 7,958 | $401k | Notice | SEC |